Phytofabrication and Characterisation of Zinc Oxide Nanoparticles Using Pure Curcumin

Zinc oxide and curcumin, on their own and in combination, have the potential as alternatives to conventional anticancer drugs. In this work, zinc oxide nanoparticles (ZnO NPs) were prepared by an eco-friendly method using pure curcumin, and their physicochemical properties were characterised. ATR-FTIR spectra confirmed the role of curcumin in synthesising zinc oxide curcumin nanoparticles (Green-ZnO-NPs). These nanoparticles exhibited a hexagonal wurtzite structure with a size and zeta potential of 27.61 +/- 5.18 nm and -16.90 +/- 0.26 mV, respectively. Green-ZnO-NPs showed good activity towards studied bacterial strains, including Escherichia coli, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. The minimum inhibitory concentration of Green-ZnO-NPs was consistently larger than that of chemically synthesised ZnO NPs (Std-ZnO-NPs) or mere curcumin, advocating an additive effect between the zinc oxide and curcumin. Green-ZnO-NPs demonstrated an efficient inhibitory effect towards MCF-7 cells with IC50 (20.53 +/- 5.12 mu g/mL) that was significantly lower compared to that of Std-ZnO-NPs (27.08 +/- 0.91 mu g/mL) after 48 h of treatment. When Green-ZnO-NPs were tested against Artemia larvae, a minimised cytotoxic effect was observed, with LC50 being almost three times lower compared to that of Std-ZnO-NPs (11.96 +/- 1.89 mu g/mL and 34.60 +/- 9.45 mu g/mL, respectively). This demonstrates that Green-ZnO-NPs can be a potent, additively enhanced combination delivery/therapeutic agent with the potential for anticancer therapy.

Automated summary

Zinc oxide nanoparticles (Green-ZnO-NPs) were prepared using pure curcumin and showed additive antimicrobial and anticancer effects with curcumin. The physicochemical properties of Green-ZnO-NPs were characterised, and their inhibitory effect on bacterial strains and cancer cells was evaluated. The results demonstrated that Green-ZnO-NPs have potential as an alternative therapeutic agent for cancer treatment.